Physician profile
Casey J Shea
NPI 1679066617
$2,092.17
in general payments reported to CMS, 2019-2025
28 companies · $568 in 2025
The $568 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $105 · 2022: $236 · 2023: $575 · 2024: $608 · 2025: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,663 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,662.79 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $474.85 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $226.94 | 2023-2025 | |
| Coloplast Corp | $155.05 | 2023-2024 | Speedicath, Porges Coloplast |
| Janssen Biotech, INC. | $133.27 | 2022-2024 | Akeega, Balversa, Erleada |
| 180 Medical, INC. | $122.36 | 2021-2024 | |
| Progenics Pharmaceuticals, INC. | $121.67 | 2023-2024 | Pylarify |
| Astellas Pharma US INC | $116.37 | 2023-2024 | Myrbetriq, Xtandi, Veozah |
| Urovant Sciences INC | $99.90 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $87.28 | 2021-2022 | |
| Urogen Pharma, INC. | $87.18 | 2025 | |
| Convatec INC. | $72.84 | 2023 | |
| Immunitybio, INC. | $53.01 | 2024-2025 | |
| Tolmar, INC. | $49.43 | 2023-2024 | |
| Teleflex LLC | $30.76 | 2023-2025 | Urolift |
| Axonics, INC. | $29.46 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $28.81 | 2025 | Illuccix |
| Myriad Genetic Laboratories, INC. | $25.71 | 2023 | |
| Merck Sharp & Dohme LLC | $21.98 | 2024 | Lynparza, Keytruda, Welireg |
| Smith+Nephew, INC. | $17.92 | 2023 | Stravix Pl |
| Myovant Sciences INC. | $17.49 | 2021 | |
| Laborie Medical Technologies Corp. | $17.19 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Vertex Pharmaceuticals Incorporated | $16.37 | 2024 | |
| Baxter Healthcare | $16.20 | 2022 | |
| Photocure INC | $15.65 | 2024 | Cysview |
| Melinta Therapeutics, LLC | $15.25 | 2024 | Rezzayo |
| Boston Scientific Corporation | $14.61 | 2022 | |
| Amgen INC. | $12.96 | 2023 | Prolia |
| Abbvie INC. | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Shea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.